Dapagliflozin/sitagliptin
Jump to navigation
Jump to search
Combination of | |
---|---|
Dapagliflozin | SGLT-2 inhibitor |
Sitagliptin | DPP-4 inhibitor |
Clinical data | |
Trade names | Sidapvia |
Pregnancy category |
|
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status |
Dapagliflozin/sitagliptin, sold under the brand name Sidapvia, is a fixed-dose combination anti-diabetic medication used for the treatment of type 2 diabetes.[1] It contains dapagliflozin, as propanediol monohydrate, a SGLT-2 inhibitor; and sitagliptin, as phosphate monohydrate, a DPP-4 inhibitor.[1] It is taken by mouth.[1]
References
- ^ a b c d e "Archived copy". Archived from the original on 8 July 2024. Retrieved 8 July 2024.
{{cite web}}
: CS1 maint: archived copy as title (link) - ^ "Sidapvia (AstraZeneca Pty Ltd)". Therapeutic Goods Administration (TGA). 1 July 2024. Archived from the original on 7 July 2024. Retrieved 8 July 2024.
- ^ "Sidapvia 10/100 dapagliflozin 10 mg (as propanediol monohydrate)/sitagliptin 100 mg (as phosphate monohydrate) film coated tablets blister pack (405540)". Therapeutic Goods Administration (TGA). 8 June 2024. Archived from the original on 8 July 2024. Retrieved 8 July 2024.
- ^ Dunleavy K (24 July 2023). "AstraZeneca enlists SK Chemicals to produce diabetes combo drug Sidapvia". Fierce Pharma. Retrieved 8 July 2024.
Categories:
- CS1 maint: archived copy as title
- Articles with short description
- Short description with empty Wikidata description
- Use American English from July 2024
- All Wikipedia articles written in American English
- Use dmy dates from July 2024
- Drugs with non-standard legal status
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Drugs that are a combination of chemicals
- Dipeptidyl peptidase-4 inhibitors
- Drugs developed by AstraZeneca
- Combination diabetes drugs
- SGLT2 inhibitors
- All stub articles
- Pharmacology stubs